Market revenue in 2020 | USD 3,357.4 million |
Market revenue in 2028 | USD 11,325.2 million |
Growth rate | 16.4% (CAGR from 2020 to 2028) |
Largest segment | (crispr)/cas9 |
Fastest growing segment | (CRISPR)/Cas9 |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.7% in 2020. Horizon Databook has segmented the UK mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
The significant growth rate of this country’s market can be attributed to permissions granted by regulatory agencies for application of gene editing technologies on human embryos. The Human Fertilization and Embryology Authority (HFEA) approved a license to a scientist at Francis Crick institute, London, to perform gene editing on human embryos to attain better understanding of early embryonic development.
In 2016, the UK became the first country to allow genetic modifications in embryo stage, along with being the first country to permit legal replacement of an embryo with a third person’s genes. Thus, rapid adoption of geneediting technology for stem cell research, regenerative therapy, and drug discovery are anticipated to boost the market for mutation detection kits in the UK.
According to an article published in May 2021, the UK government is changing rules for transgenic plants and animals. This is expected to accelerate research and stimulate investments in the country, supplementing the market’s growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UK mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into UK mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account